Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vitro comparison of Citrus/Cydonia and its single components on immune markers in seasonal allergic rhinitis
NL-OMON34748Active, not recruiting
- Sponsor
- WALA Heilmittel GmbH
- Start
- May 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of citrus e fructibus + cydonia e fructibus and cydonia fruit in seasonal allergic rhinitis (SAR) (3 arms), sponsored by WALA Heilmittel GmbH. Primary endpoints: PBMC proliferation capacity, Cell viability and 9 more. Started May 2010; status: active, not recruiting.
02
Drugs
citrus e fructibus + cydonia e fructibuscydonia fruit
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NL-OMON34748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34748.